FLNA

Filana Therapeutics Inc

$1.20

0.03 (2.46%) Today

0.01 (0.62%) After-hours

— up— down

Compare FLNA

Market Cap

$57M-34.3%

Revenue (TTM)

Net Income (TTM)

$-77,909,537

EPS (TTM)

-1.61

Shares Out

48.31M

Open

$1.19

Previous Close

$1.22

Day Range

$1.17 – $1.23

52-Week Range

$1.15 – $4.98

Beta

1.32

Earnings Date

Aug 12, 2026

Volume

215.14K

Avg Volume

394.48K

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About FLNA

Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.